View all newsletters
Receive our newsletter – data, insights and analysis delivered to you

H&T Presspart

Metal and Plastic Respiratory Drug Delivery Components and Devices

H&T Presspart specialises in the development of custom drug delivery components made from metal or plastic.

Whitebirk Industrial Estate,
BB1 5RF,
United Kingdom
H&T Presspart's laboratory.

H&T Presspart specialises in the development of custom drug delivery components made from metal or plastic.

Optimising products from concept to delivery, the company studies and refines its processes to ensure optimum performance and quality.

Metered-dose inhaler (MDI) canisters and actuators

H&T Presspart has more than 45 years’ experience of supplying metal metered-dose-inhalers (MDI), which are produced using the deep drawing method. The company offers a complete range of canisters including 10ml, 14ml, 17ml, and 19ml capacities designed for full compatibility with the actuator, valve, and drug formulation of the MDI.

H&T Presspart’s canister portfolio is suitable for use with hydrofluoroalkane (HFA) and chlorofluorocarbon (CFC) propellants.

Pressparts has state-of-the-art manufacturing facilities.
The company has clean room standard facilities.
We provide a range of dispensing actuators.
Pressparts provides metered-dose inhaler actuators.
We develop metered-dose inhaler canisters.
eMDI: the market ready smart connected metered dose inhaler (MDI).
PowdAir Plus is a capsule-based dry powder inhaler.
The Quantum dose indicator system for metered dose inhalers (MDI).

As one of the leading suppliers of MDI components, H&T Presspart produces a comprehensive range of MDI actuators, which are made from a wide range of plastic resins. One or two piece actuators are available for both solution and suspension formulations. Key features include tight dimensional tolerances, a reliable manufacturing process, and the ability to withstand extreme temperatures.

Plasma surface treatment technology for MDI canisters

H&T Presspart’s sub-micron plasma surface treatment improves the surface energy performance of an MDI canister. This helps prevent deposition of active drug content on the canister wall to improve dosing efficiency and enhance drug stability performance, which ultimately helps extend shelf life and reduce product degradation. Connected smart MDIs

Launched in partnership with Cohero Health, H&T Presspart’s fully-connected electronic metered-dose inhaler (eMDI) is designed to improve adherence and optimise care for patients with asthma and chronic obstructive pulmonary disease (COPD). It incorporates Cohero Health’s BreatheSmart management platform, which provides tracking of controller and rescue medications, as well as real-time, clinically accurate lung function measurement.

Easy-to-use capsule based dry powder inhaler

H&T Presspart’s PowdAir Plus is a four-component, capsule-based dry powder inhaler (DPI), which is designed to be discreet. This easy-to-use device provides an accurate dose delivery in a simple and low-cost method. The patented capsule is compact and portable. This simple and innovative DPI helps reduce manufacturing assembly and production costs, while maintaining a sleek and aesthetical design.

History of H&T Presspart

Since 1970, H&T Presspart has provided DPI devices from its manufacturing sites in Germany, the UK, and Spain. This is supported by effective sales offices in India, China, the US, and South America. In addition, the firm has been established as a leading partner to many of the world’s largest pharmaceutical companies worldwide.

About the eMDI

H&T Presspart and Cohero Health are currently collaborating with pharmaceutical manufacturers who are leveraging the technology for pipeline development and value-added product differentiation.

Connected Metered Dose Inhalers

In this article, H&T Presspart's programme manager Benjamin Jung and US sales and business development director Dana Shears describe the role of connected devices in the treatment of asthma and COPD. They discuss the requirements for mass adoption and introduce their inhaler, the eDMI, which has connectivity fully enabled.

Presspart Announce New Director of Inhalation Product Technology Centre

Presspart, a division of the Heitkamp & Thumann Group and the world's leading provider of specialist metal and plastic components to the pharmaceutical industry, are pleased to announce the appointment of Ameet Sule to the position of Director of Inhalation Product Technology Centre (IPTC), effective from 15 January 2013.

21 November 2012

Presspart Plasma Technology Improves Inhaler Performance

Presspart, a division of the Heitkamp & Thumann Group, has launched a new sub-micron plasma process for coating and treating the internal surfaces of pMDI canisters. Presspart plasma coating and Presspart plasma treatment offer solutions for problems with deposition of drug suspension on the

13 September 2010

Presspart Nemo Begins Manufacturing of Six-Piece Nasal Drug Delivery Device

Presspart Nemo, the new specialist injection moulding division of Presspart, has begun manufacturing a six-piece nasal drug delivery device for GlaxoSmithKline's Avamys (fluticasone furoate), an intranasal corticosteroid treatment for allergic rhinitis. Presspart is the world's leading

21 June 2010

Presspart Leads Best Practice Manufacturing Guidance in China and India

Presspart, a division of the Heitkamp & Thumann Group, has been invited to present at the Chinese SFDA training seminar in Shanghai, on 28-29 October 2009. The seminar will focus on the importance of quality control and regulations during filling and production of pressurised metered dose

28 October 2009

Presspart Demonstrates New Drug Delivery Capabilities at Pharmapack 2009

Presspart, the world's leading provider of specialist metal components to the pharmaceutical industry, is expanding its product offerings with a new range of plastic drug delivery components. The company will be exhibiting these for the first time at Pharmapack 2009 in Paris, 21-22 January, on st

13 January 2009

Spanish Acquisition for Presspart

Blackburn-based Presspart Manufacturing Ltd, the world’s leading provider of specialist metal components to the pharmaceutical industry, today announced it has acquired Nemo, a Spanish-based provider of plastic components to the pharmaceutical and medical industry. The acquisition is an important

8 October 2008

Presspart Manufacturing Ltd

Whitebirk Industrial Estate
United Kingdom

Presspart Asia-Pacific

Shanghai 201206
Jiang Su Province

Presspart Americas

North Carolina
United States of America

Presspart GmbH & Co. KG

Am Meilenstein 8 - 19
34431 Marsberg

Presspart Tarragona

Avda. del Foix, s/n
43720 L'Arboç, Tarragona
Parque Empresarial 'El Foix'
Ah pamplona

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Pharmaceutical Technology